John G. Singer 1/29/25 John G. Singer 1/29/25 Houston, We Need a New Narrative Read More John G. Singer 1/25/25 John G. Singer 1/25/25 Amazon, LillyDirect and Big Market Innovation Read More John G. Singer 1/16/25 John G. Singer 1/16/25 The Keystone Advantage for Pharma Read More John G. Singer 12/29/24 John G. Singer 12/29/24 The S&P 493 Has Run Out of Ideas Read More John G. Singer 11/27/24 John G. Singer 11/27/24 Understanding the Trump Non-Linearity Read More John G. Singer 11/20/24 John G. Singer 11/20/24 Executive Leaders’ Wile E. Coyote Moment Read More John G. Singer 11/15/24 John G. Singer 11/15/24 Navigating Industry-Level Risk Read More John G. Singer 10/30/24 John G. Singer 10/30/24 Escaping McKinseyLand is Hard, Even for McKinsey Read More John G. Singer 9/25/24 John G. Singer 9/25/24 A Note on the “Perverse Rebate System” in Action this Week Read More John G. Singer 9/24/24 John G. Singer 9/24/24 The “Strategic Direction” Thing Read More John G. Singer 9/11/24 John G. Singer 9/11/24 A “Radical” Strategy Story for Nestlé Read More John G. Singer 9/6/24 John G. Singer 9/6/24 A Note on the Launch of “PfizerForAll” Read More John G. Singer 9/3/24 John G. Singer 9/3/24 When Big PBM Business Models Are “Dead Men Walking” Read More John G. Singer 8/22/24 John G. Singer 8/22/24 Can Big Pharma Save Big Food? Read More John G. Singer 8/13/24 John G. Singer 8/13/24 How to Save UnitedHealthcare from Strategic Collapse Read More John G. Singer 8/6/24 John G. Singer 8/6/24 CVS Health Tinkers, Teladoc Totters, Moderna Tanks Read More John G. Singer 7/25/24 John G. Singer 7/25/24 How to Make Express Scripts Irrelevant in One Slide Read More John G. Singer 7/11/24 John G. Singer 7/11/24 Big PBMs and Big Market Power: Who Really Controls the Practice of Medicine in the United States? Read More John G. Singer 7/2/24 John G. Singer 7/2/24 Structural Collapse at Walgreens Read More John G. Singer 6/19/24 John G. Singer 6/19/24 The Connection Pharma is Not Making in Cannes Read More Newer Posts Older Posts
John G. Singer 1/25/25 John G. Singer 1/25/25 Amazon, LillyDirect and Big Market Innovation Read More
John G. Singer 10/30/24 John G. Singer 10/30/24 Escaping McKinseyLand is Hard, Even for McKinsey Read More
John G. Singer 9/25/24 John G. Singer 9/25/24 A Note on the “Perverse Rebate System” in Action this Week Read More
John G. Singer 9/3/24 John G. Singer 9/3/24 When Big PBM Business Models Are “Dead Men Walking” Read More
John G. Singer 8/13/24 John G. Singer 8/13/24 How to Save UnitedHealthcare from Strategic Collapse Read More
John G. Singer 8/6/24 John G. Singer 8/6/24 CVS Health Tinkers, Teladoc Totters, Moderna Tanks Read More
John G. Singer 7/25/24 John G. Singer 7/25/24 How to Make Express Scripts Irrelevant in One Slide Read More
John G. Singer 7/11/24 John G. Singer 7/11/24 Big PBMs and Big Market Power: Who Really Controls the Practice of Medicine in the United States? Read More
John G. Singer 6/19/24 John G. Singer 6/19/24 The Connection Pharma is Not Making in Cannes Read More
